Circular 29 April 2026: Non-availability of Ethambutol 400mg Tablets
The availability of ethambutol 400 mg tablets is currently constrained. Although the Affordable Medicines Directorate (AMD) has identified a supplier willing to supply the tablets; deliver is only expected around mid‑May 2026. The existing ethambutol stock is due to expire at the end of April 2026. As there may be reluctance to issue medicines expiring within a month, the Cluster: Tuberculosis (T
The availability of ethambutol 400 mg tablets is currently constrained. Although the Affordable Medicines Directorate (AMD) has identified a supplier willing to supply the tablets; deliver is only expected around mid‑May 2026.
The existing ethambutol stock is due to expire at the end of April 2026. As there may be reluctance to issue medicines expiring within a month, the Cluster: Tuberculosis (TB) Control and Management in conjunction with AMD, is providing this interim guidance.